Disease Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

ID DOID:9053
Name bladder carcinoma in situ
Definition An in situ carcinoma that is located_in the bladder.
Source DiseaseOntology.org
Alt Ids
Path disease disease of cellular proliferation pre-malignant neoplasm in situ carcinoma bladder carcinoma in situ

Filtering

  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"

Sorting

  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Molecular Profile Therapy Indication/Tumor Type Response Type Profile Response Detail
Unknown unknown Valrubicin bladder carcinoma in situ not applicable detail...
Unknown unknown BCG solution bladder carcinoma in situ not applicable detail...
Unknown unknown Oportuzumab monatox bladder carcinoma in situ not applicable detail...
Unknown unknown Pembrolizumab bladder carcinoma in situ not applicable detail...
Clinical Trial Phase Therapies Title Recruitment Status
NCT03091660 Phase III BCG Tokyo-172 Strain Solution BCG solution Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer Recruiting
NCT03106610 Phase I Nivolumab Trial of Anti-PD-1 (Nivolumab) in Bladder Cancer Patients Recently Treated With Intravesical BCG Immunotherapy Terminated